-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - Many patients with T2DM fail to meet treatment goals and require additional
therapy with one of two … New treatments in development for all types of diabetes focus on several aspects of prevention to
delay … treatment compliance
Experts agreed that while any new therapy for the treatment of diabetes would … of T2DM
Intervention
SGLT2 inhibitors for treatment of T2DM
While many current treatments help … A paradigm shift in diabetes therapy--
dapagliflozin and other SGLT2 inhibitors.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - Many patients with T2DM do not meet treatment goals and require additional therapy
with one of two … New treatments in development for all types of diabetes focus on delaying onset of the disease
in at-risk … One expert with a clinical perspective
also noted that initiation of treatment with this therapy might … Both treatments
were generally well tolerated. … Treatment Adherence
Diabetes Mellitus Interventions
Artificial Pancreas for Treatment of Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - ) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes
Mellitus Requiring Insulin 5
Fluocinolone … New treatments in development for all types of diabetes focus on delaying disease onset in at-
risk … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and … of Type 2 Diabetes Mellitus
Two therapies for treating T2DM, one in development and one recently approved … of Diabetes
Buccal Insulin (Oral-Lyn) Therapy for Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients
and … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and … therapies. … Other treatment options, such as anti-VEGF therapies are available for treating DME, and
according … Intarcia Therapeutics. A study to evaluate ITCA
650 for the treatment of type 2 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - New treatments in development for diabetes focus on delaying disease onset in at-risk patients
and … of Type 2 Diabetes Mellitus
Key Facts: Two therapies for treating T2DM, one in development and one … These studies evaluated the safety and efficacy of EQW compared with other diabetes
therapies. … ., anti-VEGF therapies). … Intarcia Therapeutics. A study to evaluate ITCA
650 for the treatment of type 2 diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - therapeutic effects and better glycemic control. … The mode of
delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is
controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new
intervention just another treatment option … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - In
a May 2015 review published in Diabetes Technology & Therapeutics of almost 21,000
patients who … 2
diabetes mellitus (T2DM) do not meet treatment goals and require additional therapy with one of … medications, behavioral and lifestyle
therapies, glucose monitors, insulin pumps, and treatment protocols … medications, behavioral and lifestyle therapies, glucose
monitors, insulin pumps, and treatment protocols … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - of Type 2 Diabetes
Key Facts: ITCA 650 (Intarcia Therapeutics, Inc., Hayward, CA), is extended-release … The mode of
delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is
controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new
intervention just another treatment option … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - with type 2
diabetes mellitus (T2DM) do not meet treatment goals and require additional therapy with … medications, behavioral and lifestyle
therapies, glucose monitors, insulin pumps, and treatment protocols … medications, behavioral and lifestyle therapies, glucose
monitors, insulin pumps, and treatment protocols … with diabetes to improve compliance with recommended therapy and success at
attaining treatment goals … Investigational
therapeutic options in the management of DME:
investigational pharmacologic treatments
-
effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - mellitus, and to collect evidence on dental treatments influencing diabetes outcomes. … Any Non-Periodontal Dental
Services Before or During Particular Treatments for Persons with Diabetes … : 46%
• Differences in criteria adopted
for the definition of periodontitis
• Differences across therapeutic … review
Corbella 2023 36849595 Laser treatments as an
adjunct to non-surgical
periodontal therapy … and Metabolic
Effects of two Periodontal
Therapeutic Modalities in
Diabetic Patients with
Residual
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - Table A: Inclusion/Exclusion Criteria
KQ1a(Pharmacologic treatments) KQ2a(Pharmacologic treatments) … KQ1b(Non-pharmacologic treatments) KQ2b(Non-pharmacologic
For prevention of DPN Complications treatments … [tiab] OR therapies[tiab]) AND (moving[tiab] OR
sports[tiab])))
OR “Stair Navigation”[tiab] OR postural … therapy”[tiab] OR “cognitive Psychotherapy”[tiab]
OR “behavioral therapy”[tiab] OR “behavioral therapies … Xylocaine (Lidocaine) AstraZeneca
Qutenza (Capsaicin) Acorda Therapeutics, Inc
20
!
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
October 01, 2012 - The benefits
and harms of treatments were considered in this review
to determine the downstream effects … glucose monitoring, insulin therapy (all preparations), and
oral hypoglycemic agents versus no treatment … For the remaining Key Questions, we may be missing
unpublished and/or negative therapy studies and may … Therapeutic interventions. Diabetes Care.
1998;21(Suppl 2):B131-37. PMID: 9704240.
39. … Use of fetal
ultrasound to select metabolic therapy for pregnancies
complicated by mild gestational
-
effectivehealthcare.ahrq.gov/products/treatment-outcomes-diabetes/rapid-research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - in the treatment
of advanced type 2 diabetes (TrIED
study-II). … Efficacy and safety of treatment
with sitagliptin or glimepiride in
patients with type 2 diabetes … Safety and
efficacy of linagliptin as add-on
therapy to metformin in patients with
type 2 diabetes … Pharmacological treatment of the
pathogenetic defects in type 2
diabetes: the randomized multicenter … HDL-C increased with both treatments, with
pioglitazone treatment resulting in a greater increase.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0658-140831.pdf
July 19, 2014 - Topic 0556 CE of Treatments for Diabetic Peripheral Neuropathy NSD SJ clean … Comparative Effectiveness of Treatments … specifically at
diabetic neuropathy progression or symptoms, such as lifestyle modifications, medical
therapies … , complementary therapies, physical therapy, electrical nerve stimulation, and
surgery
Comparator(s) … of diabetic
peripheral neuropathy in several treatment classes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
June 05, 2014 - diabetes, the mainstay of treatment for T1DM is insulin. … , and treatment. … Guidance for Industry: Diabetes Mellisuts:
Developing Drugs and Therapeutic Biologics for Treatment … Simultaneous comparison of multiple treatments:
combining direct and indirect evidence. … Behavior Therapy/
12. Blood Glucose Self-Monitoring/
13. Cognitive Therapy/
14.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_executive.pdf
January 01, 2015 - Executive Summary
Condition and Therapeutic
Strategies
Type 2 diabetes affects more than
9.3 percent … to treat type
2 diabetes when tolerated, and it supports a number of
treatment options that might … Oral pharmacologic
treatment of type 2 diabetes mellitus: a clinical practice guideline
from the American … American Diabetes Association. (7) Approaches to glycemic
treatment. … Diabetes Medications for Adults With Type 2 Diabetes: An Update Executive Summary
Condition and Therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications … and Treatment of Symptoms of Diabetic Peripheral Neuropathy
Source: www.effectivehealthcare.ahrq.gov … Protocol
Project Title: Transparency of Repor ting Requirements
Repor t Topic: Effectiveness of Treatments … Options for the Prevention of Complications
and Treatment of Symptoms of Diabetic Peripheral Neuropathy … neuropathy and health-related quality of life among
adults age 18 or older with type 1 or type 2 diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-mobile-devices_research-protocol.pdf
July 12, 2017 - 1 diabetes, Type 2 diabetes, and gestational diabetes.4 Type 2 diabetes represents approximately
90 … to 95% of all patients with diabetes, while Type 1 diabetes accounts for 5%. … Best treatments for depression. … Apr 2017;
http://www.consumerreports.org/cro/2013/09/best-treatments-for-depression/index.htm. … 12, 2017
7
http:www.effectivehealthcare.ahrq.gov
http://www.consumerreports.org/cro/2013/09/best-treatments-for-depression